Vimta Labs Ltd Share Price

Understanding Vimta Labs Share Price, Operations and Earnings

Vimta Labs is a Contract Research Organisation (CRO) and testing laboratory. Vimta Labs offers services in multiple sectors. These include the pharmaceutical, biological, food, agricultural, medical device, speciality chemical and allied sectors. As a CRO, Vimta Labs offers analytical and preclinical services and clinical research. The company also provides testing services in food, environmental and agricultural sectors. The main source of income of the company is testing, research and allied scientific services. The performance of these business segments is of interest to investors tracking the Vimta Labs share price.

Vimta Labs Journey, Growth and Major Milestones

• 1984: Establishment — Vimta Labs began as a company that provided research and testing services. It has since ventured into pharmaceuticals, food, agriculture, and environment testing.
• 2021: National Food Laboratory — In collaboration with FSSAI, Vimta Labs established the National Food Laboratory at JNPT, Navi Mumbai. This initiative was carried out in a 25-year Public-Private Partnership (PPP).
• 2024: Diagnostics & Pathology Business Divestment — Vimta Labs entered into an agreement to divest the diagnostics and pathology business to Thyrocare Technologies. The divestment was successfully concluded in October 2024.
• 2024-25: Service Expansion — Vimta Labs expanded its testing services to areas such as food, environment, medical devices and electronics. It also provides research services for biologics and biosimilars. Investors may consider these areas when assessing the Vimta share price.

Vimta Labs Leadership, Management and Business Strategy

Vimta Labs' leadership team shapes its business strategy and operations, which investors may consider when evaluating the Vimta Labs share price.

• Harita Vasireddi: Managing Director
• Harriman Vungal: Executive Director – Operations
• Dr S. P. Vasireddi: Non-Executive Chairman and Founder
• Smt. Prameela Rani: Non-Executive Director
• Dr Yadagiri Pendri: Non-Executive Director

The company's strategy focuses on expanding its testing and contract research capabilities while developing new service areas.

Vimta Labs ESG, Sustainability and Business Practices

Vimta Labs focuses on environmental management, laboratory safety, quality and employee-related practices. It uses energy-efficient equipment and LED lighting to reduce energy use. Its testing and research follow relevant standards and certifications. Investors may consider these factors along with the Vimta Labs share price.

Vimta Labs Awards, Achievements and Industry Recognition

Vimta Labs has certifications and accreditations such as NABL, GLP and AAALAC. Its facilities have also undergone regulatory audits in several countries. These support its pharmaceutical and biopharmaceutical research work and may be considered when evaluating the Vimta Labs stock price.

Vimta Labs Stock Price, Financial Performance and Key Metrics

Vimta Labs is focused on building its clinical research and testing business. The company's revenues from operations in the first 9 months of FY26 were Rs. 2,980 million, as against Rs. 2,495 million for the same period in FY25.

For FY26, the company expects revenues to be in the range of Rs. 4,000 million to Rs. 4,150 million. EBITDA for the first nine months of FY26 was Rs. 1,068 million. In Q3 FY26, the company reported operations revenue of Rs. 986 million and EBITDA of Rs. 344 million with an EBITDA margin of 34.3%.

Vimta Labs stock is trading around ₹522.45. The 52-week high and low are ₹735.00 and ₹376.05, respectively. A few other things investors may consider for valuation are P/B ratio, ROE, ROCE, debt-equity ratio, cash flows and other things of that nature.

Besides the above, investors also assess PAT, EPS, margins, financial debt, various assets, cash flows, etc., while evaluating the Vimta Labs stock price.